Head and neck cancer research platform
Part of Cancer clinical trials.
This trial is collecting information and blood samples from people with head and neck cancer that cannot be cured. It aims to learn more about the cancer and find better ways to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have head and neck squamous cell carcinoma (a type of cancer in the mouth, throat, or voice box)
- Your cancer cannot be cured, and you are getting treatments to control it or only supportive care
- You are able to understand and sign a consent form
- You agree to join the study within a set time after starting treatment or after finding out about recurrence or spread
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks for specific signs in your blood and tumor tissue that may show how well immunotherapy is working for recurrent or metastatic head and neck cancer. It aims to help doctors personalize treatment in the future.
This study uses tumor tissue taken from people with head and neck cancer, then grows it in a lab to better understand the cancer and predict responses. If you have a new or returning cancer and can share key medical details and follow-up information, you may be able to take part.
This study collects blood plasma samples from people with squamous cell cancer of the head and neck. Researchers want to better understand how treatments work, based on your prior cancer therapy, which may help future care.
This study collects tissue from people with newly diagnosed head and neck squamous cell cancer and grows “mini tumor models” in the lab. The goal is to see how these models respond to new therapies, which may help guide more effective treatment choices in the future.
This trial is for people with head and neck cancer that has not spread to distant parts of the body. It is a non-treatment study that will look at the molecular features of your tumor from a biopsy sample to help guide future treatment decisions.
This study enrolls adults with a first-time head and neck cancer diagnosis and collects health and treatment information to better understand the disease. It may help clinicians improve care by learning which treatments and patient features matter most.
Hear when a new Squamous Cell Carcinoma of the Hypopharynx trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.